MTIP AG

Type

Private equity

Status

Active

Location

Basel, Switzerland

Total investments

18

Average round size

20M

Portfolio companies

13

Rounds per year

1.80

Lead investments

5

Follow on index

0.28

Exits

1

Stages of investment
Private Equity
Areas of investment
SoftwareArtificial IntelligenceMachine LearningHealth CareHospitalEnterprise SoftwareMedical DeviceCyber SecurityNetwork SecurityMedical

Summary

In 2014 was created MTIP AG, which is appeared as VC. The venture was found in Europe in Switzerland. The main office of represented VC is situated in the Basel.

Among the most popular fund investment industries, there are Biotechnology, Robotics. The fund has no exact preference in a number of founders of portfolio startups. If startup sums 3 or 5+ of the founder, the chance for it to be financed is low. Among the most popular portfolio startups of the fund, we may highlight Lumeon, TytoCare, Cynerio. Besides, a startup needs to be aged 4-5 years to get the investment from the fund. For fund there is no match between the country of its foundation and the country of its the most frequent investments - Israel.

The important activity for fund was in 2018. The fund is generally included in 2-6 deals every year. Speaking about the real fund results, this VC is 23 percentage points more often commits exit comparing to other organizations. The common things for fund are deals in the range of 10 - 50 millions dollars.

The fund was created by Christoph Kausch, Felix Grisard, Hans Florian Zeilhofer.

The typical case for the fund is to invest in rounds with 4-5 participants. Despite the MTIP AG, startups are often financed by Walgreens, Teuza, OrbiMed. The meaningful sponsors for the fund in investment in the same round are High-Tech Gru00fcnderfonds, Bayern Kapital GmbH, Walgreens. In the next rounds fund is usually obtained by TechWald Holding S.p.A., Shenzhen Capital Group, Sanford Health.

Show more

Investor highlights

Geo focus
AlbaniaAustriaBelgiumBosnia and HerzegovinaBulgaria Show 38 more
Check size
Up to 55M

Discover reliable insights

Find relevant VC investors, identify key contacts and secure funding opportunities.

Investments analytics

Analytics

Total investments
18
Lead investments
5
Exits
1
Rounds per year
1.80
Follow on index
0.28
Investments by industry
  • Health Care (17)
  • Medical Device (8)
  • Medical (5)
  • Artificial Intelligence (5)
  • Hospital (4)
  • Show 24 more
Investments by region
  • United Kingdom (4)
  • United States (4)
  • Spain (2)
  • Belgium (1)
  • France (1)
  • Show 4 more
Peak activity year
2021

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
9
Avg. valuation at time of investment
26M
Group Appearance index
0.83

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Inlaylink 29 Aug 2006 Manufacturing, RFID, Satellite Communication Seed 309K Shanghai, China
NitiNotes 25 Mar 2020 Health Care, Medical Device, Medical Early Stage Venture 7M Tel Aviv District, Tel Aviv-Yafo, Israel
NitiNotes 25 Sep 2023 Health Care, Medical Device, Medical Early Stage Venture 10M Tel Aviv District, Tel Aviv-Yafo, Israel
Oasis Technology 15 Feb 2000 Internet, Software, Payments Early Stage Venture 25M Ontario, Old Toronto, Canada
Testfire Labs 15 Nov 2017 Software, Artificial Intelligence, Machine Learning, Intelligent Systems, Natural Language Processing, Meeting Software Seed 1M Canada, Alberta, Edmonton

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.